Document is current
Any future updates will be listed below
-
Authors
Schlager, Hansjörg https://orcid.org/0009-0001-7765-3152
Baumann-Durchschein, Franziska
Steidl, Karin
Häfner, Michael
Dinkhauser, Patrick
Weitersberger, Michael
Holzinger, Josef
Mader, Markus
Gröchenig, Hans Peter
Madl, Christian
Schreiner, Philipp
-
Funding
Funding for this research was provided by:
Medical University of Graz
- License Information
-
More Information
Article History
Received: 25 March 2024
Accepted: 21 June 2024
First Online: 4 September 2024
Conflict of interest
: H. Schlager received consulting and speakers fees from Falk Pharma, Sanofi, Medtronic. F. Baumann-Durchschein received speakers fees from Falk Pharma, Sanofi. K. Steidl received consulting and speakers fees from Takeda, Abbvie, Falk Pharma, Janssen, Galapagos. P. Dinkhauser received consulting and speakers fees from Falk Pharma, Sanofi, Abbvie, MSD, Takeda, Janssen, Pfizer. M. Mader received speakers fees and congress support from Falk Pharma, Boston Scientific, Abbvie. H.P. Gröchenig received speakers fees Falk Pharma, Sanofi. P. Schreiner received consulting and speakers fees from Abbvie, Galapagos, Ferring, Falk Pharma, Pfizer, Sanofi, Takeda, Janssen-Cilag, Eli Lilly. M. Häfner, M. Weitersberger, J. Holzinger and C. Madl declare that they have no competing interests.
